Aberrant Methylation and Reduced Expression of LHX9 in Malignant Gliomas of Childhood

High-grade gliomas (HGGs) of childhood represent approximately 7% of pediatric brain tumors. They are highly invasive tumors and respond poorly to conventional treatments in contrast to pilocytic astrocytomas, which usually are well demarcated and frequently can be cured by surgery. The molecular e...

Full description

Bibliographic Details
Main Authors: Valentina Vladimirova, Thomas Mikeska, Andreas Waha, Niels Soerensen, Jingying Xu, Patrick C. Reynolds, Torsten Pietsch
Format: Article
Language:English
Published: Elsevier 2009-07-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558609800225
id doaj-9de070dbd6e347bd87967fe4e3a00521
record_format Article
spelling doaj-9de070dbd6e347bd87967fe4e3a005212020-11-24T22:39:23ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022009-07-0111770071110.1593/neo.09406Aberrant Methylation and Reduced Expression of LHX9 in Malignant Gliomas of ChildhoodValentina Vladimirova0Thomas Mikeska1Andreas Waha2Niels Soerensen3Jingying Xu4Patrick C. Reynolds5Torsten Pietsch6Department of Neuropathology, University of Bonn Medical Center, Bonn, GermanyDepartment of Neuropathology, University of Bonn Medical Center, Bonn, GermanyDepartment of Neuropathology, University of Bonn Medical Center, Bonn, GermanyDepartment of Pediatric Neurosurgery, University of Wuerzburg, Wuerzburg, GermanyUSC-CHLA Institute for Pediatric Clinical Research, Children Hospital Los Angeles and The University of Southern California Keck School of Medicine, Los Angeles, CA, USAUSC-CHLA Institute for Pediatric Clinical Research, Children Hospital Los Angeles and The University of Southern California Keck School of Medicine, Los Angeles, CA, USADepartment of Neuropathology, University of Bonn Medical Center, Bonn, Germany High-grade gliomas (HGGs) of childhood represent approximately 7% of pediatric brain tumors. They are highly invasive tumors and respond poorly to conventional treatments in contrast to pilocytic astrocytomas, which usually are well demarcated and frequently can be cured by surgery. The molecular events for this clinical relevant finding are only partially understood. In the current study, to identify aberrantly methylated genes that may be involved in the tumorigenesis of pediatric HGGs, we performed a microarray-based differential methylation hybridization approach and found frequent hypermethylation of the LHX9 (human Lim-homebox 9) gene encoding a transcription factor involved in brain development. Bisulfite genomic sequencing and combined bisulfite restriction analysis showed that HGGs were frequently methylated at two CpG-rich LHX9 regions in comparison to benign, nondiffuse pilocytic astrocytomas and normal brain tissues. The LHX9 hypermethylation was associated with reduced messenger RNA expression in pediatric HGG samples and corresponding cell lines. This epigenetic modification was reversible by pharmacological inhibition (5-aza-2′-deoxycytidine), and reexpression of LHX9 transcript was induced in pediatric glioma cell lines. Exogenous expression of LHX9 in glioma cell lines did not directly affect cell proliferation and apoptosis but specifically inhibited glioma cell migration and invasion in vitro, suggesting a possible implication of LHX9 in the migratory phenotype of HGGs. Our results demonstrate that the LHX9 gene is frequently silenced in pediatric malignant astrocytomas by hypermethylation and that this epigenetic alteration is involved in glioma cell migration and invasiveness. http://www.sciencedirect.com/science/article/pii/S1476558609800225
collection DOAJ
language English
format Article
sources DOAJ
author Valentina Vladimirova
Thomas Mikeska
Andreas Waha
Niels Soerensen
Jingying Xu
Patrick C. Reynolds
Torsten Pietsch
spellingShingle Valentina Vladimirova
Thomas Mikeska
Andreas Waha
Niels Soerensen
Jingying Xu
Patrick C. Reynolds
Torsten Pietsch
Aberrant Methylation and Reduced Expression of LHX9 in Malignant Gliomas of Childhood
Neoplasia: An International Journal for Oncology Research
author_facet Valentina Vladimirova
Thomas Mikeska
Andreas Waha
Niels Soerensen
Jingying Xu
Patrick C. Reynolds
Torsten Pietsch
author_sort Valentina Vladimirova
title Aberrant Methylation and Reduced Expression of LHX9 in Malignant Gliomas of Childhood
title_short Aberrant Methylation and Reduced Expression of LHX9 in Malignant Gliomas of Childhood
title_full Aberrant Methylation and Reduced Expression of LHX9 in Malignant Gliomas of Childhood
title_fullStr Aberrant Methylation and Reduced Expression of LHX9 in Malignant Gliomas of Childhood
title_full_unstemmed Aberrant Methylation and Reduced Expression of LHX9 in Malignant Gliomas of Childhood
title_sort aberrant methylation and reduced expression of lhx9 in malignant gliomas of childhood
publisher Elsevier
series Neoplasia: An International Journal for Oncology Research
issn 1476-5586
1522-8002
publishDate 2009-07-01
description High-grade gliomas (HGGs) of childhood represent approximately 7% of pediatric brain tumors. They are highly invasive tumors and respond poorly to conventional treatments in contrast to pilocytic astrocytomas, which usually are well demarcated and frequently can be cured by surgery. The molecular events for this clinical relevant finding are only partially understood. In the current study, to identify aberrantly methylated genes that may be involved in the tumorigenesis of pediatric HGGs, we performed a microarray-based differential methylation hybridization approach and found frequent hypermethylation of the LHX9 (human Lim-homebox 9) gene encoding a transcription factor involved in brain development. Bisulfite genomic sequencing and combined bisulfite restriction analysis showed that HGGs were frequently methylated at two CpG-rich LHX9 regions in comparison to benign, nondiffuse pilocytic astrocytomas and normal brain tissues. The LHX9 hypermethylation was associated with reduced messenger RNA expression in pediatric HGG samples and corresponding cell lines. This epigenetic modification was reversible by pharmacological inhibition (5-aza-2′-deoxycytidine), and reexpression of LHX9 transcript was induced in pediatric glioma cell lines. Exogenous expression of LHX9 in glioma cell lines did not directly affect cell proliferation and apoptosis but specifically inhibited glioma cell migration and invasion in vitro, suggesting a possible implication of LHX9 in the migratory phenotype of HGGs. Our results demonstrate that the LHX9 gene is frequently silenced in pediatric malignant astrocytomas by hypermethylation and that this epigenetic alteration is involved in glioma cell migration and invasiveness.
url http://www.sciencedirect.com/science/article/pii/S1476558609800225
work_keys_str_mv AT valentinavladimirova aberrantmethylationandreducedexpressionoflhx9inmalignantgliomasofchildhood
AT thomasmikeska aberrantmethylationandreducedexpressionoflhx9inmalignantgliomasofchildhood
AT andreaswaha aberrantmethylationandreducedexpressionoflhx9inmalignantgliomasofchildhood
AT nielssoerensen aberrantmethylationandreducedexpressionoflhx9inmalignantgliomasofchildhood
AT jingyingxu aberrantmethylationandreducedexpressionoflhx9inmalignantgliomasofchildhood
AT patrickcreynolds aberrantmethylationandreducedexpressionoflhx9inmalignantgliomasofchildhood
AT torstenpietsch aberrantmethylationandreducedexpressionoflhx9inmalignantgliomasofchildhood
_version_ 1725709099600969728